FGFR3 and central nervous system cancer: As mentioned above, strong immunoexpression of FGFR3 was reported in the majority of F3T3 gliomas and mainly in areas showing the typical recurrent morphological features, suggesting that neoplastic cells in these zones could have the highest activation of FGFR3 downstream signaling [20].